Lv3
292 积分 2024-03-04 加入
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
9天前
已完结
The association of genetic testing timing and mutation type on breast cancer management in patients with breast cancer-related mutations
11天前
已完结
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing
19天前
已完结
Liquid biopsy biomarkers in breast cancer: An overview of systematic reviews
19天前
已完结
[Guideline for HER2 testing in breast cancer (2024 version)]
19天前
已完结
Diagnostic utility of ESR1 mutation detection in liquid biopsy of metastatic breast cancer patients
19天前
已完结
Antibody–drug conjugates come of age in oncology
19天前
已完结
Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases
20天前
已完结
The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases
20天前
已完结
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
20天前
已完结
皖公网安备34019202002308
